2022-2023 Cost Recovery Implementation Statement (CRIS)

Page last updated: 12 August 2022

The 2022-23 Pharmaceutical Benefits Scheme (PBS) and National Immunisation Program (NIP) Cost Recovery Implementation Statement (CRIS) is now available on the PBS Cost Recovery Fees and Charges webpage. The CRIS provides information for industry on how the Department administers cost recovery arrangements and sets out the fees that will apply to PBS/NIP applications for the 2022-23 financial year.

Additionally, the PBS activity-based cost model underwent an independent review in 2022, addressing clause 6.2 of the current Strategic Agreement between the Commonwealth Government and Medicines Australia. The Executive Summary of the review findings is now available on the PBS Cost Recovery Fees and Charges webpage.

Background

Public consultation on the draft 2022-23 CRIS was undertaken in June 2022. The published 2022-23 CRIS incorporates stakeholder feedback received.

If you have any questions regarding these updates please email PBScostrecovery@health.gov.au